The RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer.

Söderlund Leifler, K

The RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer. [electronic resource] - Journal of cancer research and clinical oncology May 2015 - 797-804 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1432-1335

10.1007/s00432-014-1859-0 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant
Cyclophosphamide--administration & dosage
Cytosine
Female
Fluorouracil--administration & dosage
Gene Expression Regulation, Neoplastic
Genetic Predisposition to Disease
Genotype
Guanine
Humans
Mastectomy, Segmental
Methotrexate--administration & dosage
Middle Aged
Neoplasm Recurrence, Local--prevention & control
Polymerase Chain Reaction--methods
Polymorphism, Restriction Fragment Length
Polymorphism, Single Nucleotide
Predictive Value of Tests
Prognosis
Rad51 Recombinase--genetics
Radiotherapy, Adjuvant
Sequence Analysis, DNA
Treatment Outcome